Ionis Pharmaceuticals, Inc. (IONS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.66B |
| Enterprise Value | 14.9B |
| P/E Ratio | -8.75 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 5.03 |
| Price/Book Ratio | 12.27 |
| Enterprise/Revenue | 6.97 |
| Enterprise/EBITDA | -14.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.57 |
| Operating Margin | -0.59 |
AD
Management Effectiveness
| Return On Assets | -0.19 |
| Return On Equity | -1.2 |
Income Statement
| Revenue | 944M |
| Revenue/Share | 5.77 |
| Gross Profit | 928M |
| EBITDA | -284.31M |
| Net Income | -381M |
| Diluted EPS | -2.38 |
Balance Sheet
| Total Cash | 1.88B |
| Total Cash/Share | 11.33 |
| Total Debt | 2.15B |
| Total Debt/Equity | 5.47 |
| Current Ratio | 5.43 |
| Book Value Per Share | 2.37 |
Price History
| 52-Week Change | -59.89 |
| 52-Week High | 86.74 |
| 52-Week Low | 27.75 |
| Moving Average 50 Days | 45.55 |
| Moving Average 200 Days | 65.31 |
Statistics
| Average Volume | 3.6M |
| Shares Outstanding | 166.18M |
| % Held by Institutions | 109.65 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
